In this episode of our Spotlight on Women's Health and Innovation podcast, Maria Ryan and Melissa Dix explore how patenting trends offer...

The historical western approach of relying on internally-developed blockbuster drugs to drive growth is now under strain. Patent expiries...

The women’s health sector is undergoing significant transformation. A major driving force for this is the evolution of AI and the impact...

The global biopharmaceutical industry entered 2026 facing one of the largest waves of patent expirations in its history. The potential...

At the time the Commission published its “Proposal for a regulation to simplify rules on medical and in vitro diagnostic devices”, making...

We wrote recently about the European Commission’s proposals to simplify the EU Medical Device Regulation (“MDR”)[1] and EU In Vitro...

There is so much legislative change in the EU and UK in the life sciences sector at the moment that it is sometimes difficult to keep up...

Those working in the Femtech space have a difficult regulatory framework to navigate in the EU. For products that qualify as a medical...

After years in the making, the much-awaited political agreement reached by the EU institutions on the so-called “EU pharma package” will...

The European Commission has published its long-awaited proposal for a regulation to simplify the EU Medical Devices Regulation (“EU...

The European Commission has recently published a draft implementing regulation under the EU Medical Devices Regulations (“EU MDR”)[1] and...

In this third, and final, article of our three-part series - Thinking early: key legal points for early-stage biotech companies - we are...